Dr. Stephan Mayer: “Hyperosmolar Therapy Yields Worse Results in Primary ICH Patients, Database Review Shows”
In a prospective review of data from one of the largest registries on intracerebral hemorrhage outcomes, researchers observed that those who had received hyperosmolar therapy had worse outcomes than those who did not receive the treatment. “Statistical attempts to match patient groups that are fundamentally different have limitations,” said Stephan Mayer, MD, Professor of Neurology and Neurological Surgery and Director of the Institute for Critical Care Medicine at the Icahn School of Medicine at Mount Sinai, who was not involved with the study. “You can basically match or control for certain variables related to disease severity but you really can't control for everything.” Learn more
Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
Mar 02, 2023 View All Press Releases
Researchers Identify the Role of an Alzheimer’s Disease Risk Gene in the Brain
Nov 30, 2022 View All Press Releases
